Tuesday, August 9, 2022
Stop Diabetes
No Result
View All Result
  • Home
  • Diabetes
  • Diabetic Lifestyle
  • The Best Habits
  • Reversing Diabetes
  • Diabetes Nutrition
  • Shop
  • Contact Us
No Result
View All Result
  • Home
  • Diabetes
  • Diabetic Lifestyle
  • The Best Habits
  • Reversing Diabetes
  • Diabetes Nutrition
  • Shop
  • Contact Us
No Result
View All Result
Stop Diabetes
No Result
View All Result
Home Diabetes Diabetic Medication

EOFlow launches world’s 2nd wearable insulin pump

diabetes-admin by diabetes-admin
March 31, 2021
in Diabetic Medication
0
EOFlow launches world’s 2nd wearable insulin pump
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter


EOFlow, a medical gadget developer, stated Monday that it has launched the world’s second wearable insulin pump, EOPatch.


EOFLow CEO Kim Jae-jin stated Monday that the corporate has launched its wearable insulin pump, EOPatch, for the second time on this planet.


“The insulin remedy has been exhibiting speedy developments past insulin pen and glucose meters and heading towards a one-in-system combining insulin pump, steady glucose monitoring, and insulin patch,” Professor Park Cheol-young of the Division of Endocrinology at Kangbuk Samsung Hospital stated at a information convention.  


Park stated that it’s essential to implement an built-in administration system able to decreasing hyperglycemia and hypoglycemia by making use of algorithms to observe blood glucose stage, insulin dosage, and drugs historical past to enhance blood sugar controls.


Park emphasised the necessity to develop an answer that reduces the variety of administration and improves the comfort of use by enhancing the mounted injection time.


EOPatch is a disposable insulin pump permitting improved lesion administration by injecting insulin into the physique by attaching it to the stomach. It repeatedly delivers insulin to diabetic sufferers for his or her blood sugar administration.


The corporate has improved the convenience of use by eradicating the tube from the prevailing insulin pumps. The gadget is waterproof with reduces dimension and weight and permits weekly substitute by customers.


EOFlow designed the wearable patch controllable by the Superior Diabetes Supervisor (ADM) and EOBridge, analyzing statistical diabetes information. EOBridge gives customers’ blood glucose stage and injection historical past via an app or web site, and the information might be shared with guardians and healthcare suppliers.


Commenting on the gadget’s doable malfunctioning, EOFlow CEO Kim Jae-jin defined that the corporate has examined security with hundreds of its product samples and reported no issues.


He identified that the EOPatch instantly alarms customers when it malfunctions or reads glucose meter incorrectly and stops functioning.


“We’ve got signed an settlement with Menarini to produce EOPatch to the European market, and in addition contacted with numerous corporations for its U.S. provide,” CEO Kim stated. “For the subsequent scientific trials to be carried out in different nations, we’ve got optimistic outlooks for recruiting.”


Kim added that the corporate envisions brilliant development prospects for its product sooner or later, as tens of tens of millions of sufferers use multiple-dose insulin (MDI) injections, who’ve begun switching to wearable gadgets.


EOFlow is stepping up its growth efforts to commercialize wearable synthetic pancreas in 2022 and all-in-one wearable synthetic pancreas in 2023.



Source link

READ ALSO

Invokana (Canagliflozin) Oral: Uses, Side Effects, Dosage

Mounting Medicine Bills? This Startup Helps You Save Up To 80% on Each Prescription

Tags: 2ndEOFlowinsulinlaunchesPumpwearableWorlds

Related Posts

Invokana (Canagliflozin) Oral: Uses, Side Effects, Dosage
Diabetic Medication

Invokana (Canagliflozin) Oral: Uses, Side Effects, Dosage

August 4, 2022
Mounting Medicine Bills? This Startup Helps You Save Up To 80% on Each Prescription
Diabetic Medication

Mounting Medicine Bills? This Startup Helps You Save Up To 80% on Each Prescription

August 4, 2022
First Interchangeable Biosimilar to Lucentis Launches
Diabetic Medication

First Interchangeable Biosimilar to Lucentis Launches

August 4, 2022
At CAGR of 5.9% Global Ophthalmic Drugs Market Size & Share | 2022 – 2028 | Projected to Hit at USD 60.31 Billion: Industry Trends, Value, Analysis & Forecast Report by Zion Market Research
Diabetic Medication

At CAGR of 5.9% Global Ophthalmic Drugs Market Size & Share | 2022 – 2028 | Projected to Hit at USD 60.31 Billion: Industry Trends, Value, Analysis & Forecast Report by Zion Market Research

August 4, 2022
At CAGR of 5.9% Global Ophthalmic Drugs Market Size & Share | 2022 – 2028 | Projected to Hit at USD 60.31 Billion: Industry Trends, Value, Analysis & Forecast Report by Zion Market Research
Diabetic Medication

$13.4+ Billion Global Needle-Free Diabetes Care Market Size Likely to Grow at 6.7% CAGR During 2022-2028 | Industry Trends, Share, Growth, SWOT Analysis, Forecast by Zion Market Research

August 4, 2022
‘Dr Pimple Popper’ Season 8: Can Dr Lee treat Robert’s Eruptive Xanthomas given his heart condition?
Diabetic Medication

‘Dr Pimple Popper’ Season 8: Can Dr Lee treat Robert’s Eruptive Xanthomas given his heart condition?

August 4, 2022

POPULAR NEWS

Fruit Street Health launches employer advisory board to manage healthcare costs with digital health

Fruit Street Health launches employer advisory board to manage healthcare costs with digital health

March 30, 2021
Glucofort Reviews (Warning) Fake Results or Real Ingredients?

Glucofort Reviews (Warning) Fake Results or Real Ingredients?

July 31, 2021
GlucoFreeze Reviews: Shocking Scam Complaints to Know About?

GlucoFreeze Reviews: Shocking Scam Complaints to Know About?

August 11, 2021
Glucofort Reviews (UPDATED) Scam Reports or Real Customer Success Stories?

Glucofort Reviews (UPDATED) Scam Reports or Real Customer Success Stories?

May 14, 2021
CrossFit Coach Helps Greg Upchurch Shed 140 Pounds, Put Diabetes into Remission During COVID

CrossFit Coach Helps Greg Upchurch Shed 140 Pounds, Put Diabetes into Remission During COVID

May 5, 2021

EDITOR'S PICK

How Ataxia-Telangiectasia Is Treated – Verywell Health

How Ataxia-Telangiectasia Is Treated – Verywell Health

October 12, 2021
What you should know about the most underrated form of exercise – Daily Journal Online

What you should know about the most underrated form of exercise – Daily Journal Online

August 8, 2021
Open-Source Insulin: Biohackers Aiming For Distributed Production

Open-Source Insulin: Biohackers Aiming For Distributed Production

August 23, 2021
Professor Lee Byoung-kwon of Gangnam Severance Hospital

Professor Lee Byoung-kwon of Gangnam Severance Hospital

September 13, 2021

Recent Posts

  • 3 commonly asked questions about breastfeeding and chestfeeding, answered by a lactation consultant
  • Just 2 Minutes of Walking After a Meal Is Surprisingly Good for You
  • How to Use the Principle of Specificity for Exercise
  • Realistic Ways To Limit Processed Foods In Your Diet
  • Man With Diabetes, Depression Missing in Maywood – Vigour Times

Categories

  • Alternative Therapies for Diabetes
  • Diabetes
  • Diabetes
  • Diabetes Education
  • Diabetes Nutrition
  • Diabetes Tips
  • Diabetes Types
  • Diabetes Videos
  • Diabetic Insurance
  • Diabetic Lifestyle
  • Diabetic Medication
  • Diabetic Shop
  • Diabetic Specialists – Doctors
  • Prediabetes
  • Reversing Diabetes
  • Sports
  • Symptoms
  • The Best Habits

Follow us

Contact Us

  • Privacy & Policy
  • About Us
  • Contact Us

© 2021 Stop Diabetes

No Result
View All Result
  • Home
  • Diabetes
  • Diabetic Lifestyle
  • The Best Habits
  • Reversing Diabetes
  • Diabetes Nutrition
  • Shop
  • Contact Us

© 2021 Stop Diabetes

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?